ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) saw a significant decrease in short interest in December. As of December 15th, there was short interest totalling 4,800 shares, a decrease of 25.0% from the November 30th total of 6,400 shares. Based on an average daily volume of 5,700 shares, the days-to-cover ratio is presently 0.8 days.
ZIVO Bioscience Stock Up 18.5 %
Shares of ZIVOW stock opened at $0.77 on Friday. The stock has a 50-day simple moving average of $0.68 and a 200 day simple moving average of $0.76. ZIVO Bioscience has a fifty-two week low of $0.23 and a fifty-two week high of $1.52.
Get
ZIVO Bioscience alerts:
Hedge Funds Weigh In On ZIVO Bioscience
A hedge fund recently raised its stake in ZIVO Bioscience stock. Warberg Asset Management LLC lifted its stake in ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 84,654 shares of the company's stock after purchasing an additional 69,034 shares during the quarter. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 as of its most recent filing with the Securities & Exchange Commission.
About ZIVO Bioscience
(Get Rating)
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
Featured Stories
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- Should You Warm up to Generac Stock for the Winter?
- Is Kintara Therapeutics A Hidden Gem?
- 3 High-Yield Dividend Stocks to Hold for the Long Haul
- Cal-Maine Posts Record Quarter, Remain CALM Income Investors
- Tesla Stock: What the Bulls and the Bears Are Getting Wrong
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
齊沃生物科學公司(納斯達克:ZIVOW-GET評級)看到空頭股數在12月份大幅下降。截至12月15日,空頭股數共有4800股,比11月30日的6400股減少了25.0%。以日均成交量5,700股計算,目前天數與回補比率為0.8天。
Zivo生物科學類股上漲18.5%
上週五,ZIVOW股票開盤報0.77美元。該股的50日簡單移動均線切入位為0.68美元,200日簡單移動均線切入位為0.76美元。Zivo Bioscience的股價為0.23美元,為52周低點,52周高點為1.52美元。
到達
Zivo生物科學警報:
對沖基金參與Zivo Bioscience
一家對沖基金最近增持了Zivo Bioscience股票。華平資產管理公司最近提交給美國證券交易委員會的檔案顯示,該公司第三季度將其在Zivo Bioscience,Inc.(納斯達克代碼:ZIVOW-GET Rating)的持股比例提高了442.0%。該公司在本季度額外購買了69,034股後,擁有84,654股公司股票。截至最近提交給美國證券交易委員會(Securities&Exchange Commission)的檔案,華寶資產管理有限公司在Zivo Bioscience持有的股份價值5.1萬美元。
關於Zivo生物科學
(獲取評級)
Zivo Bioscience,Inc.是一家總部位於密歇根州的生物技術/AgTech公司,致力於利用從其專有藻類培養物中提取的生物活性化合物的免疫健康和營養益處。正在開發的產品包括用作膳食補充劑和功能性食品配料的天然產品,以及旨在為人類和動物提供醫療和製藥益處的創新、生物衍生和合成候選產品,重點是調節免疫和炎症反應。
專題報道
- 免費獲取StockNews.com關於Zivo生物科學的研究報告(ZIVOW)
- 你應該暖身到Generac股票過冬嗎?
- 金塔拉治療公司是一顆隱藏的寶石嗎?
- 長期持有的3只高收益股利股票
- 加州緬因州公佈創紀錄的季度業績,保持冷靜的收入投資者
- 特斯拉股票:公牛和熊隊哪裡出了問題
獲得Zivo生物科學日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Zivo Bioscience和相關公司的最新新聞和分析師評級的每日簡要摘要。